Form 4 for BIIB Biogen
Accepted 2025-02-11 00:00:00 ET · period of report 2025-02-07 · accession 0001127602-25-004243 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| DM | 2025-02-11 | 2025-02-07 | BIIB | Izzar Rachid | Head of Gbl Product Strat | F - Tax | $141.35 | -1,165 | 6,059 | -16% | -$164.7K |
| DM | 2025-02-11 | 2025-02-07 | BIIB | Izzar Rachid | Head of Gbl Product Strat | M - OptEx | $0.00 | +3,844 | 7,224 | +114% | $0 |
| DM | 2025-02-11 | 2025-02-07 | BIIB | Izzar Rachid | Head of Gbl Product Strat | M - OptEx | $0.00 | -3,844 | 2,044 | -65% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2025-02-07 | F | D | 600 | $141.35 | 6,624 | D | — | — | |
| 2 | Common | Common Stock | 2025-02-07 | M | A | 1,801 | $0.00 | 7,860 | D | — | — | |
| 3 | Common | Common Stock | 2025-02-07 | M | A | 2,043 | $0.00 | 7,224 | D | — | — | (F1) Total adjusted to reflect transfer of shares to the reporting person's former spouse pursuant to a Domestic Relations Order. |
| 4 | Common | Common Stock | 2025-02-07 | F | D | 565 | $141.35 | 6,059 | D | — | — | |
| 5 | Derivative | Restricted Stock Unit | 2025-02-07 | M | D | 1,801 | $0.00 | 3,604 | D | $0.00 · — to 2027-02-07 | 1,801 Common Stock | (F3) The restricted stock units vest in three (3) equal annual installments, commencing one year after the grant date of 02/07/2024. |
| 6 | Derivative | Restricted Stock Unit | 2025-02-07 | M | D | 2,043 | $0.00 | 2,044 | D | $0.00 · — to 2026-02-08 | 2,043 Common Stock | (F2) The restricted stock units vest in three (3) equal annual installments commencing one year after the grant date of 02/08/2023. |